Indications and uses
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
before using this product, read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: vaginal insert: with the applicator, place the vaginal insert into the vagina. Throw away applicator. external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina. Use 2 times daily f...
Drug Facts
Miconazole nitrate 1200 mg (in each vaginal insert) Vaginal antifungal
Miconazole nitrate 2% (external cream) Vaginal antifungal
For vaginal use only
if you have never had a vaginal yeast infection diagnosed by a doctor.
taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur.
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
vaginal insert: gelatin, glycerin, lecithin, mineral oil, titanium dioxide, white petrolatum
external cream: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol
If you have any questions or comments, please call 1-877-666-4782.
1-DAY
TREATMENT
Day or Night Stays in Place
MONISTAT® 1
COMBINATION PACK
Miconazole Nitrate Vaginal Insert (1200 mg) and
Miconazole Nitrate Cream (2%) – Vaginal Antifungal
1-DAY
TREATMENT
MAXIMUM STRENGTH
1 OVULE® Insert Net Wt. 2.6 g +0.32oz (9g) Tube
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 992778 | {1 (miconazole nitrate 1200 MG Vaginal Insert [Monistat]) / 1 (9000 MG) (miconazole nitrate 20 MG/ML Vaginal Cream [Monistat]) } Pack [Monistat 1 Day Ovule Combination Pack] | BPCK | 7 |
| 992775 | {1 (miconazole nitrate 1200 MG Vaginal Insert) / 1 (9000 MG) (miconazole nitrate 20 MG/ML Vaginal Cream) } Pack | GPCK | 7 |
| 992775 | miconazole 1 day - (1200 MG insert / 2 % cream 9 GM) Pack | PSN | 7 |
| 992774 | miconazole nitrate 1200 MG Vaginal Insert | PSN | 7 |
| 998540 | miconazole nitrate 2 % Vaginal Cream | PSN | 7 |
| 992778 | Monistat 1 Day Ovule Combination Pack | PSN | 7 |
| 992777 | Monistat 1200 MG Vaginal Insert | PSN | 7 |
| 998541 | Monistat 2 % Vaginal Cream | PSN | 7 |
| 992777 | miconazole nitrate 1200 MG Vaginal Insert [Monistat] | SBD | 7 |
| 998541 | miconazole nitrate 20 MG/ML Vaginal Cream [Monistat] | SBD | 7 |
| 992774 | miconazole nitrate 1200 MG Vaginal Insert | SCD | 7 |
| 998540 | miconazole nitrate 20 MG/ML Vaginal Cream | SCD | 7 |
| 992778 | {1 (miconazole nitrate 1200 MG Vaginal Insert [Monistat]) / 1 (0.32 OZ) (miconazole nitrate 2 % Vaginal Cream [Monistat]) } Pack [Monistat 1 Day Ovule Combination Pack] | SY | 7 |
| 992774 | miconazole nitrate 1.2 GM Vaginal Insert | SY | 7 |
| 998540 | miconazole nitrate 2 % Vaginal Cream | SY | 7 |
| 992778 | Monistat 1 Day Ovule Combination Pack | SY | 7 |
| 992777 | Monistat 1200 MG Vaginal Insert | SY | 7 |
| 998541 | Monistat 20 MG/ML Vaginal Cream | SY | 7 |
| Class | Version | Type | Effective |
|---|---|---|---|
| MICONAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 3a55f4fb-5aec-4c88-0ff7-4d608ad4866a | Product name | 1 | 20140508 |
| 5b9a7965-36d2-8412-dcaf-f76a65411611 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63736-013-30 | 2020-02-20 | C162847 | 48780-1 | 9d75b9d0-9fd9-f424-e053-dadaa90a57ce | Monistat 1 COMBINATION PACK_Suppository-tube_63736-013-30 |
| 63736-013-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9fd9-f424-e053-dadaa90a57ce | Monistat 1 COMBINATION PACK_Suppository-tube_63736-013-30 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-013-30 | Monistat 1 Combination Pack | 1 in 1 PACKAGE, COMBINATION | KIT | 1 | 7 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Miconazole Nitrate | ACTIVE INGREDIENT | VW4H1CYW1K | 2 | |
| Miconazole | ACTIVE MOIETY | 7NNO0D7S5M | 2 | |
| Benzoic Acid | INACTIVE INGREDIENT | 8SKN0B0MIM | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Isopropyl Myristate | INACTIVE INGREDIENT | 0RE8K4LNJS | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 2 | |
| Potassium Hydroxide | INACTIVE INGREDIENT | WZH3C48M4T | 2 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| Stearyl Alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-013 | 63736-013-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Miconazole Nitrate | VW4H1CYW1K | ACTIB |
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| Miconazole Nitrate | VW4H1CYW1K | ACTIB |
| Benzoic Acid | 8SKN0B0MIM | IACT |
| Cetyl Alcohol | 936JST6JCN | IACT |
| Isopropyl Myristate | 0RE8K4LNJS | IACT |
| Polysorbate 60 | CAL22UVI4M | IACT |
| Potassium Hydroxide | WZH3C48M4T | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Water | 059QF0KO0R | IACT |
| Stearyl Alcohol | 2KR89I4H1Y | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | TABLET, COATED / ORAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 14 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL, METERED / TRANSDERMAL | 50 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | LOTION / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | SYRUP / ORAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO, SUSPENSION / TOPICAL | 2 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| Gelatin | GELATIN | 2G86QN327L | PASTE / DENTAL | 252 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | TABLET, FILM COATED / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | CREAM / VAGINAL | 200 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | FILM / TRANSDERMAL | 58.08 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SYSTEM / TRANSDERMAL | 113 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, ORALLY DISINTEGRATING / ORAL | 9 mg | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | AEROSOL, FOAM / TOPICAL | 37 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021308-001 | MONISTAT 1 COMBINATION PACK | MICONAZOLE NITRATE | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | f41ea6bd6efb… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | ea99ee380514… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Monistat 1 Combination Pack | MICONAZOLE NITRATE | Insight Pharmaceuticals LLC | 97ff1c90-c250-4921-81af-6a56cc9cc7d2 | 2026-04-20 | Warnings | 63736-013-30 63736-013 63736001330 50061b4b-e817-4ed7-8f2f-be4a17baf152 97ff1c90-c250-4921-81af-6a56cc9cc7d2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.